Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺49.084,1, with a 24-hour trading volume of ₺104,64B. The asset's market cap is ₺43,77T, after moving -0.02% in the last day.
Tokenized Eli Lilly And Co is trading at ₺48.974,85, with a tokenized market cap of ₺276,79M and a 24-hour trading volume of ₺102,22M. The tokenized asset has moved -0.97% in the past 24 hours.